Sol Gel Technologies Ltd banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Israel IL
Employees
28
IPO date
Feb 1, 2018

Sol-Gel Technologies is a dermatology drug company that develops and sells prescription treatments for skin conditions. Its core work is to formulate medicines in topical gel form, which are applied directly to the skin rather than taken by mouth. The company’s products have focused on common problems such as acne and rosacea, and it also has worked on other skin-disease treatments.

The company makes money by commercializing its own branded prescription products and, in some cases, by partnering with larger drug companies to develop or market products. Its main customers are doctors, pharmacies, patients, and pharmaceutical partners involved in dermatology care. That means Sol-Gel sits in the part of the drug industry that turns skin treatments into finished medicines and then moves them through the prescription channel.

What makes its business model different is its focus on topical formulations and skin-specific drug delivery. Instead of trying to build a broad medicine portfolio, it concentrates on a narrow area where the form of the drug matters as much as the active ingredient. For investors, that makes Sol-Gel a specialized dermatology company whose value depends on successful product development, regulatory approvals, and adoption by prescribers.

Sol Gel Technologies Ltd Investor Relations

Address
Golda Meir 7
Ness Ziona, Central(HaMerkaz)
Israel

Business Segments

Licensed dermatology products

Sol-Gel licenses its skin treatment products to commercial partners, who handle marketing and sales in the market. The company’s products are used by doctors and patients for conditions such as acne and rosacea.

Customers and revenue model

Pipeline development

Sol-Gel develops new topical medicines using its silica-based technology and moves them through testing and regulatory review. These programs are aimed at skin diseases that still need approved treatments.

Customers and revenue model

Management

Dr. Alon Seri-Levy

Co-Founder, CEO & Director

Biography unavailable

Dr. Itzik Yosef

Chief Operating Officer

Biography unavailable

Mr. Gilad Mamlok

Advisor

Biography unavailable

Mr. Moshe Arkin

Executive Chairman of the Board

Biography unavailable

Prof. David Avnir

Co-Founder

Biography unavailable

Mr. Eyal Ben-Or

Chief Financial Officer

Biography unavailable

Ms. Tamar Fishman Jutkowitz

VP & General Counsel

Biography unavailable

Dr. Karine Neimann

VP of Projects & Planning and Chief Chemist

Biography unavailable

1 / 8